 |
|
ADHD medications do not cause genetic damage in children
November 20, 2008In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke University Medical Center.
The study published online this month in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) provides new evidence that therapeutic doses of stimulant medications, such as methylphenidate and amphetamine, do not cause cytogenetic (chromosomal) damage in humans. The researchers looked at three measures of cytogenetic damage in white blood cells of each child participating in the study and found no evidence of any changes after three months of continuous treatment.
"This is good news for parents," said Kristine L. Witt, M.Sc., a genetic toxicologist at the National Institute of Environmental Health Sciences (NIEHS) and co-author on the study, which was funded through the Best Pharmaceuticals for Children Act by NIEHS and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both parts of NIH. "Our results indicate that methylphenidate- and amphetamine-based products do not induce cytogenetic damage in children."
The researchers involved emphasize that the findings should not be interpreted as final proof of the long-term safety of stimulant drugs for the treatment of ADHD. "More research and close monitoring of children taking these medications for extended periods of time is needed to fully evaluate the physical and behavioral effects of prolonged treatment with stimulants," noted Scott H. Kollins, Ph.D., director of the Duke ADHD Program, where the study was conducted and a co-author of the paper.
ADHD is a disorder characterized by attention problems, impulsivity, and hyperactivity. About 3 to 5 percent of children in the United States have been diagnosed with the disorder, although several studies suggest 7 to 12 percent of children may be affected.
The current study included 63 children, ranging from 6-12 years of age, who met full criteria for ADHD but who had not previously been treated with stimulant medications. Children in the study were divided into two groups and treated by a board-certified child psychiatrist with either methylphenidate (commercially available as Ritalin LA and Concerta) or with mixed amphetamine salts (Adderall and Adderall XR). Blood samples were taken before the medication was started to establish baseline values for the cytogenetic measures that were analyzed in the study, and a second sample was collected after three months of continuous treatment. Forty-seven children completed the full three-month treatment schedule.
The researchers found no significant differences between the two groups of children with regard to age, gender, race, body weight, height, or ADHD subtype. The groups also showed very similar ADHD symptom levels at initial screening and children in both groups responded equally well to the medication.
The researchers looked at three standard indicators of chromosomal damage: structural chromosomal aberrations (breaks in chromosomes), micronuclei (small nuclei consisting of chromosome fragments produced by breakage or whole chromosomes lost from the main nucleus after the cell divides), and sister chromatid exchanges (exchanges of genetic material between a pair of identical chromosomes). "We did not see any significant treatment-related increases in any of these three endpoints," said Donald R. Mattison, M.D., senior advisor to the director at NICHD. "These results add to a growing body of evidence that therapeutic levels of these medications do not damage chromosomes," he said.
The study was designed to determine the reproducibility of findings from a previously published paper that reported methylphenidate-induced chromosomal changes in children with ADHD. That paper raised concern for the medical community and parents, given that some of the changes have been associated with an increased risk of cancer. The current study was not able to replicate the findings from the previous study. The new JAACAP paper extends the literature by using a larger sample size than previous studies, investigating more than one commonly prescribed medication, and providing well-characterized results that can be generalized to other ADHD populations.
"One way scientists evaluate each other's work is by attempting to reproduce the original experiment or study," said Witt. "We designed a study with specific modifications to address issues raised with the original study. Thus, our results are based on a significantly larger number of children who were carefully evaluated using rigorous, accepted standards, which allowed us to produce high-confidence data at the end of our study."
NIH/National Institute of Environmental Health Sciences
The researchers involved emphasize that the findings should not be interpreted as final proof of the long-term safety of stimulant drugs for the treatment of ADHD. "More research and close monitoring of children taking these medications for extended periods of time is needed to fully evaluate the physical and behavioral effects of prolonged treatment with stimulants," noted Scott H. Kollins, Ph.D., director of the Duke ADHD Program, where the study was conducted and a co-author of the paper.
ADHD is a disorder characterized by attention problems, impulsivity, and hyperactivity. About 3 to 5 percent of children in the United States have been diagnosed with the disorder, although several studies suggest 7 to 12 percent of children may be affected.
The current study included 63 children, ranging from 6-12 years of age, who met full criteria for ADHD but who had not previously been treated with stimulant medications. Children in the study were divided into two groups and treated by a board-certified child psychiatrist with either methylphenidate (commercially available as Ritalin LA and Concerta) or with mixed amphetamine salts (Adderall and Adderall XR). Blood samples were taken before the medication was started to establish baseline values for the cytogenetic measures that were analyzed in the study, and a second sample was collected after three months of continuous treatment. Forty-seven children completed the full three-month treatment schedule.
The researchers found no significant differences between the two groups of children with regard to age, gender, race, body weight, height, or ADHD subtype. The groups also showed very similar ADHD symptom levels at initial screening and children in both groups responded equally well to the medication.
The researchers looked at three standard indicators of chromosomal damage: structural chromosomal aberrations (breaks in chromosomes), micronuclei (small nuclei consisting of chromosome fragments produced by breakage or whole chromosomes lost from the main nucleus after the cell divides), and sister chromatid exchanges (exchanges of genetic material between a pair of identical chromosomes). "We did not see any significant treatment-related increases in any of these three endpoints," said Donald R. Mattison, M.D., senior advisor to the director at NICHD. "These results add to a growing body of evidence that therapeutic levels of these medications do not damage chromosomes," he said.
The study was designed to determine the reproducibility of findings from a previously published paper that reported methylphenidate-induced chromosomal changes in children with ADHD. That paper raised concern for the medical community and parents, given that some of the changes have been associated with an increased risk of cancer. The current study was not able to replicate the findings from the previous study. The new JAACAP paper extends the literature by using a larger sample size than previous studies, investigating more than one commonly prescribed medication, and providing well-characterized results that can be generalized to other ADHD populations.
"One way scientists evaluate each other's work is by attempting to reproduce the original experiment or study," said Witt. "We designed a study with specific modifications to address issues raised with the original study. Thus, our results are based on a significantly larger number of children who were carefully evaluated using rigorous, accepted standards, which allowed us to produce high-confidence data at the end of our study."
NIH/National Institute of Environmental Health Sciences
ADHD Current Events and ADHD News RSSExperts unveil new CVD guidelines and position papers
Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.
Eating liquorice in pregnancy may affect a child's IQ and behavior
Expectant mothers who eat excessive quantities of liquorice during pregnancy could adversely affect their child's intelligence and behaviour, a study has shown.
Are the monoamines involved in shaping conduct disorders?
Antisocial and aggressive behaviours represent a widespread and expensive social problem. Recent research has convincingly shown that there is a strong interaction between genetic inheritance and environment for development of personality and behaviour.
Vyvanse CII significantly improved ADHD symptoms for children 13 hours after administration
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse® (lisdexamfetamine dimesylate) CII significantly reduced the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 from the first time point measured (1.5 hours) up to the last time point assessed (13 hours) after administration.
ADHD genes found, known to play roles in neurodevelopment
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD.
Measuring intellectual disability
Researchers from the University of California, Davis have developed a specific and quantitative means of measuring levels of the fragile X mental retardation 1 (FMR1) protein (FMRP), which is mutated in fragile X syndrome.
Could hormones explain gender differences in neurological disease?
Neurological diseases including Parkinson's, Tourette's, attention deficit hyperactivity disorder (ADHD), Alzheimer's, and schizophrenia are all associated with alterations in dopamine-driven function involving the dopamine transporter (DAT).
MIT: Long-distance brain waves focus attention
Just as our world buzzes with distractions - from phone calls to e-mails to tweets - the neurons in our brain are bombarded with messages.
History of hyperactivity off-base, says researcher
A Canadian researcher working in the U.K. says doctors, authors and educators are doing hyperactive children a disservice by claiming that hyperactivity as we understand it today has always existed.
Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find
As thousands of students nationwide prepare to leave high school, a UC Davis study appearing online today in the June issue of the medical journal Pediatrics shows a clear link between attention problems early in school - as early as kindergarten - and lower high school test scores.
More ADHD Current Events and ADHD News Articles
 |
The Survival Guide for Kids with ADD or ADHD by John F. Taylor Ph.D. (Author) What are ADD and ADHD? What does it mean to have ADD and ADHD? How can kids diagnosed with ADD and ADHD help themselves succeed in school, get along better at home, and form healthy, enjoyable relationships with peers? In kid-friendly language and a format that welcomes reluctant and easily distracted readers, Free Spirit's newest survival guide helps kids know they're not alone and offers practical strategies for taking care of oneself, modifying behavior, enjoying school, having fun, and dealing (when needed) with doctors, counselors, and medication. Includes real-life scenarios, quizzes, and a special message for parents. |
 |
Parenting Children With Adhd: 10 Lessons That Medicine Cannot Teach (APA Lifetools) by Vincent J., Ph.D. Monastra (Author) Kids with ADHD need to be loved and shown how to become successful adults. Unfortunately, their lack of attention and restlessness often get in the way. Parents of these kids try so hard to stay connected and remain patient in the face of daily frustration. However, it is an incredible challenge to remain positive and involved when your child does not respond to the kinds of strategies that work for other children. Without guidance and systematic treatment, these bright, inquisitive children are unlikely to graduate from high school, are more prone to use illegal drugs, and struggle to maintain employment as adults. Parenting Children with ADHD: Lessons That Medicine Cannot Teach gives parents a framework for building a successful parenting program at home. Drawing from his experiences in... |
 |
Dr. Bob's Guide to Stop ADHD in 18 Days by Robert DeMaria (Author) This how-to guide can rid children and families off medications and detrimental foods - junk foods loaded with sugar, preservatives, dairy products, and trans- fattyacids - so that children and families can enjoy optimal health. "This user-friendly book has the potential of setting families free from the nightmare of ADD, ADHD, and ODD. Using drugs on kids isn't solving the problem. Follow Dr. Bob's directions and witness the change is can bring to you and your loved ones." Bruce West, D.C. Publisher, Health Alert |
 |
Taking Charge of ADHD: The Complete, Authoritative Guide for Parents (Revised Edition) by Russell A. Barkley PhD ABPP ABCN (Author) A treasured parent resource since its publication, Taking Charge of ADHD has now been revised and updated to incorporate the most current information on ADHD and its treatment. From internationally renowned ADHD expert Russell A. Barkley, the book empowers parents by arming them with the up-to-date knowledge, expert guidance, and confidence they need to ensure that their child receives the best care possible. Features of the revised edition include: *A step-by-step plan for behavior management that has helped thousands of children with ADHD *Hard data that clear up current controversies about increased diagnosis and stimulant use *New strategies that give children greater chances of success at school and in social situations *Advances in genetic and neurological research... |
 |
How To Reach And Teach Children with ADD/ADHD: Practical Techniques, Strategies, and Interventions (J-B Ed: Reach and Teach) by Sandra F. Rief M.A. (Author) Sandra Rief offers myriad real-life case studies, interviews, and student intervention plans for children with ADD/ADHD. In addition, the book contains best teaching practices and countless strategies for enhancing classroom performance for all types of students. This invaluable resource offers proven suggestions for: Engaging students' attention and active participation Keeping students on-task and productive Preventing and managing behavioral problems in the classroom Differentiating instruction and addressing students' diverse learning styles Building a partnership with parents and much more. |
 |
Learning To Slow Down & Pay Attention: A Book for Kids About Adhd by Kathleen G. Nadeau (Author), Ellen B. Dixon (Author), Charles Beyl (Author) - An APA Bestseller-over 25,000 copies sold! This book is designed as the perfect learning tool to help parents guide their child as he or she confronts the challenges of ADHD. Learning to Slow Down is unique because it is kid-centered, written from the child's point of view. This updated edition includes easy-to-read text, fun cartoons, and activities, as well as loads of self-help tips for coping with friends, family, and schoolwork, getting organized, getting disciplined, and getting things done. Appropriate for ages 6-11. Full-color illustrations. |
 |
The Gift of ADHD Activity Book: 101 Ways to Turn Your Child's Problems into Strengths (Companion) by Lara, Ph.D. Honos-Webb (Author) The chapters of the book are organized by strengths that can be developed in a child. There is a short discussion of the importance of each strength, and then the book offers simple activities that parents do with their child-often in just a few minutes-to help develop them. Throughout the book strikes a positive note, stressing things that parents can do themselves to encourage and support their child rather than things they should discourage or avoid. |
 |
Driven To Distraction : Recognizing and Coping with Attention Deficit Disorder from Childhood Through Adulthood by Edward M. Hallowell (Author), John J. Ratey (Author) Through vivid stories of the experiences of their patients (both adults and children), Drs. Hallowell and Ratey show the varied forms ADD takes -- from the hyperactive search for high stimulation to the floating inattention of daydreaming -- and the transforming impact of precise diagnosis and treatment. |
 |
ADHD & Me: What I Learned from Lighting Fires at the Dinner Table by Blake E. S. Taylor (Author) Blake Taylor's memoir, written when he was 17, offers, for the first time, a young person's account of what it's like to live and grow up with this common condition. Join Blake as he foils bullies, confronts unfair teachers, struggles with distraction and disorganization on exams, and goes sailing out-of-bounds and ends up with a boatload of spiders. It will be an inspiration and companion to the millions of others like him who must find a way to thrive with a different perspective than many of us. The book features an introduction by psychologist Lara Honos-Webb, author of The Gift of ADHD, and a leading advocate for kids with ADHD. Blake's mother first suspected he had ADHD when he, at only three years of age, tried to push his infant sister in her carrier off the... |
 |
ADHD: A Complete and Authoritative Guide (American Academy of Pediatrics) by Michael I. Reiff MD FAAP Editor-in-Chief (Editor), Sherill Tippins (Editor) This comprehensive guide to attention deficit/hyperactivity disorder (ADHD) offers parents balanced, reassuring, and authoritative information to help them understand and manage this challenging and often misunderstood condition. Based on the American Academy of Pediatrics' own clinical practice guidelines for ADHD and written in clear, accessible language, this book answers the common questions: How is ADHD diagnosed?, What are today's best treatment options, and Will my child outgrow ADHD? Accurate, up-to-date findings on evaluation and diagnosis, coexisting conditions, and unproven treatments are provided. Also addressed are behaviors associated with the teenage years and what schools can do to support children with the condition. ADHD management strategies that balance the roles of... |
| © 2009 BrightSurf.com |